Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma

R. Alberts, Steven; Alkhatib, Hani; R. Mahoney, Michelle; J Burgart, L; J. Cera, Peter; J. Flynn, Patrick; R. Finch, Tom; Levitt, Ralph; E. Windschitl, Harold; A. Knost, James; K. Tschetter, Loren

doi:10.1002/cncr.20753

Public

Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma

Published in Cancer • Nov 22, 2004

Authors:

Steven R. Alberts

Hani Alkhatib

Michelle R. Mahoney

Abstract

BACKGROUND: Gemcitabine has broad activity in a variety of solid tumors including biliary tract carcinomas. The authors evaluated 6-month survival, response, and toxicity associated with a combination of gemcitabine, 5-fluorouracil (5-FU), and leucovorin (LV) in patients with unresectable or metasta...

Subject

Medicine

Gemcitabine

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!